The underrecognition and undertreatment of depression: What is the breadth and depth of the problem?

Journal of Clinical Psychiatry

Volumn 60, Issue SUPPL. 7, 1999, Pages 4-11

  Davidson, Jonathan R T ^a   Meltzer Brody, Samantha E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DEPRESSION; DISABILITY; HEALTH CARE MANAGEMENT; HEALTH CARE SYSTEM; HEALTH SURVEY; HUMAN; PRIORITY JOURNAL; REVIEW; RISK MANAGEMENT;

ANTIDEPRESSIVE AGENTS; COMORBIDITY; COST-BENEFIT ANALYSIS; DEPRESSIVE DISORDER; HEALTH CARE COSTS; HEALTH SURVEYS; HUMANS; PERSONALITY INVENTORY; PREVALENCE; PRIMARY HEALTH CARE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; UNITED STATES;

EID: 0032936222     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results of the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19
2. Robins LN, Locke BZ, Regier DA. An overview of psychiatric disorders in America. In: Robins LN, Regier DA, eds. Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York, NY: Free Press; 1991:328-366
3. Keller MB, Klerman GL, Lavori PW, et al. Treatment received by depressed patients. JAMA 1982;248:1848-1855
4. Kessler RC, Zhao S, Blazer DG, et al. Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey. J Affect Disord 1997;45:19-30
5. Keller MB, Harrison W, Fawcett JA, et al. Treatment for chronic depression with sertraline and imipramine: preliminary blinded response rate and high rates of undertreatment in the community. Psychopharmacol Bull 1995;31:205-212
6. Kocsis JH, Frances AJ, Voss C, et al. Imipramine treatment for chronic depression. Arch Gen Psychiatry 1988;45:253-257
7. Kocsis JH, Friedman RA, Markowitz JC, et al. Maintenance therapy for chronic depression: a controlled trial of desipramine. Arch Gen Psychiatry 1996;53:769-774
8. Shelton RC, Davidson J, Yonkers K, et al. The undertreatment of dysthymia. J Clin Psychiatry 1997;58:59-65
9. Katon W, von Korff M, Lin E, et al. Adequacy and duration of antidepressant treatment in primary care. Med Care 1992;30:67-76
10. Simon GE, von Korff M. Recognition, management, and outcomes of depression in primary care. Arch Fam Med 1995;4:99-105
11. Wells KB, Katon W, Rogers B, et al. Use of minor tranquilizers and antidepressant medications by depressed outpatients: results from the Medical Outcomes Study. Am J Psychiatry 1994;151:694-700
12. Goethe JW, Szarek BL, Cook WL. A comparison of adequately vs inadequately treated depressed inpatients. J Nerv Ment Dis 1988;24:75-80
13. Keller MB, Lavori PW, Lewis CE, et al. Predictors of relapse in major depressive disorder. JAMA 1983;250:3299-3304
14. Keller MB, Klerman GL, Lavori PW, et al. Long-term outcome of episodes of major depression: clinical and public health significance. JAMA 1984; 252:788-792
15. Keller MB, Lavori PW, Rice J, et al. The persistent risk of chronicity in re-current episodes of nonbipolar major depressive disorder: a prospective follow-up. Am J Psychiatry 1986;143:24-28
16. Hirschfeld RM, Keller MB, Panico S, et al. The National Depressive and Manic-Depressive Association Consensus Statement on the Undertreatment of Depression. JAMA 1997;277:333-340
17. Stimmel GL. How to counsel patients about depression and its treatment. Pharmacotherapy 1995;15(6, pt 2):100S-104S
18. Greenberg PE, Stiglin LE, Finkelstein SN, et al. The economic burden of depression in 1990. J Clin Psychiatry 1993;54:405-419
19. Greenberg PE, Stiglin LE, Finkelstein SN, et al. Depression: a neglected major iliness. J Clin Psychiatry 1993;54:419-424
20. Rupp A. The economic consequences of not treating depression. Br J Psychiatry 1995;166(suppl 27):29-33
21. von Korff M, Katon W, Bush T, et al. Treatment costs, cost offset, and cost effectiveness of collaborative management of depression. Psychosom Med 1998;60:143-149
22. Spitzer RL, Kroenke K, Linzer M, et al Health-related quality of life in primary care patients with mental disorders: results from the PRIME-MD 1000 Study. JAMA 1995;274:1511-1517
23. Üstün TB, Sartorius N, eds. Mental Illness in General Health Care: An International Study. London, England: John Wiley & Sons; 1995
24. Sartorius N, Üstün TB, Lecrubier Y, et al. Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary health care. Br J Psychiatry Suppl 1996;168(suppl 30):38-43
25. Wells KB, Golding JM, Burnam MA. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 1988;145:976-981
26. Katon W, Sullivan MD. Depression and chronic medical illness. J Clin Psychiatry 1990;51(6, suppl):3-11
27. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1988;8:77-100
28. Carroll BJ. Carroll Depression Scales Manual. North Tonawanda, NY MultiHealth Systems; 1998
29. Zung WWK. A self-rating depression scale. Arch Gen Psychiatry 1965;12 63-70
30. McCallum J, Mackimmon A, Simons L, et al. Measurement properties of the Center for Epidemiological Studies of Depression Scale: an Australian community study of aged persons. J Gerontol B Psychol Sci 1995;50: S182-S189
31. Spitzer RL, Williams JBW, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA 1994;272:1749-1755
32. Sheehan DV, et al; Lecrubier Y, et al. Mini-International Neuropsychiatrie Interview, version 5.0.0. J Clin Psychiatry 1998;59(suppl 20):34-57
33. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
34. Goldberg D. The management of anxious depression in primary care. J Clin Psychiatry 1999;60(suppl 7):39-42